Investors

Welcome to our investor resources section, where you can access comprehensive information about our financial performance and strategic initiatives. Explore our latest reports, presentations, and updates to stay informed about Vitrafy’s growth and opportunities.

ASX Announcements

DateTitle
12 Dec 2024Revised Securities Trading PolicyView Now
10 Dec 2024Change of Director's Interest NoticeView Now
27 Nov 2024Becoming a substantial holder from RYDView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
22 Nov 2024Pre-Quotation Disclosure StatementView Now
22 Nov 2024Top 20 HoldersView Now
22 Nov 2024Distribution ScheduleView Now
22 Nov 2024Securities Trading PolicyView Now
22 Nov 2024Equity Incentive Plan RulesView Now
22 Nov 2024Annual Report - 30 June 2024View Now
22 Nov 2024Annual Report - 30 June 2023View Now
22 Nov 2024ConstitutionView Now
22 Nov 2024Replacement ProspectusView Now
22 Nov 2024Information Form and ChecklistView Now
22 Nov 2024Appendix 1AView Now
22 Nov 2024ASX Market Announcement - Admission and QuotationView Now

Corporate Governance

Corporate Charters

Corporate Policies

Vitrafy Board Charter

Audit and Risk Committee Charter

Remuneration & Nomination Committee Charter

Anti Bribery and Corruption Policy

Code of Conduct

Continuous Disclosure Policy

Diversity Policy

Securities Trading Policy

Statement of Values

Whistleblower Policy

Get in Contact

Head Office

Vitrafy Life Sciences Limited

Level 4, 96–100 Albert Road, South Melbourne VIC 3205 Australia

Email: [email protected]

Share Registry

Xcend Pty Ltd

Level 2, 477 Pitt Street, Haymarket, NSW 2000 Australia

Email: [email protected]

Stay Tuned